author-photo

A. Cortellezzi

2

Papers

6

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

The hOCT1 and ABCB1 Polymorphisms Don't Condition the Efficacy and Toxicity of Nilotinib As First-Line Treatment: An Italian Multicentric Experience

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A phase II study of chlorambucil plus rituximab followed by maintenance versus observation in elderly patients with previously untreated chronic lymphocytic leukemia: Results of the induction phase.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)